Cancer News and Research

Latest Cancer News and Research

Researchers investigate new way to block reproduction of the hepatitis C virus

Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus (HCV) - targeting not the virus itself but the human genes the virus exploits in its life cycle.

20 Mar 2009

Study finds biological clue in brain tumor development

Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for a children's brain tumour that currently kills more than 60 per cent of young sufferers.

20 Mar 2009

Scots and Irish at greater risk of drink-related death, study shows

Alcohol-related deaths in England and Wales are twice as high among people born in Scotland or Ireland compared with the rest of the population, a study has shown.

20 Mar 2009

Scientists trial device to treat chemotherapy-related nausea

Trials to test acupressure wrist bands as a drug-free alternative for chemotherapy-related nausea are to take place at the University of Liverpool.

20 Mar 2009

Discovery of genetic markers for aggressive head and neck cancer

Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer.

20 Mar 2009

Research yields potential target for cancer, wound healing and fibrosis

Research conducted by Allison Berrier, PhD, Assistant Professor of Oral and Craniofacial Biology at the LSU Health Sciences Center New Orleans School of Dentistry, and colleagues, provides insights that may help scientists design novel approaches to control wound healing and fight diseases such as cancer and fibrosis.

20 Mar 2009

Biopsy of recurrent breast cancer can alter treatment

For women with recurrent breast cancer, the treatment the doctor chooses is usually based on the properties of their original breast cancer.

20 Mar 2009

PSA screening delivers a 20% reduction in mortality from prostate cancer

Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online in at NEJM, Online First.

20 Mar 2009

Improvements in prostate cancer recognition, management and treatment are needed

The prostate cancer charter for change from 13 influential European and US prostate cancer patient groups, calls for the disease to be treated with the same level of priority as breast cancer is in women.

20 Mar 2009

Potential colon cancer being tested

Researchers at the University of Pittsburgh School of Medicine have begun testing a vaccine that might be able to prevent colon cancer in people at high risk for developing the disease.

20 Mar 2009

Discovery of new protein important in breast cancer gene's role in DNA repair

For years, researchers have known that under normal conditions, the breast cancer protein BRCA1 orchestrates the repair of damaged DNA, but the details of just how BRCA1 moves to the damaged site and recruits the right nuclear repairmen for DNA restoration remains a mystery.

20 Mar 2009

Discovery of gene that plays key role in process of converting dietary carbohydrates to fat

In a new study, they disabled this gene in mice, which consequently had lower levels of body fat than their normal counterparts, despite being fed the equivalent of an 'all-you-can-eat' pasta buffet.

20 Mar 2009

Research could lead to potential new drugs for treating asthma

The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.

20 Mar 2009

Prostate cancer expert say keep screening in face of contradicting data

New data evaluating the impact of screening on mortality provides mixed messages on the value of prostate cancer screening.

20 Mar 2009

Long-term storage of green tea lessens health benefits

Green tea leaves produce antioxidant organic compounds called catechins that reportedly have beneficial health effects, such as fighting bacteria, viruses and cancer.

20 Mar 2009

Gleevec reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors

Data published online and in an upcoming print issue of The Lancet show that Gleevec (imatinib mesylate) tablets, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.

20 Mar 2009